Fig. 3From: Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapyOverall survival in 355 cervical cancer patients stratified by neutrophil-lymphocyte ratio (NLR), P < 0.001Back to article page